Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
42 Cards in this Set
- Front
- Back
Drugs used in renal disorders are grouped into two categories, what are they?
|
1. Drugs that modify salt excretion
2. Drugs that modify water excretion |
|
Drugs that modify salt excretion work on different parts of the nephron. Group the class of drug with the appropriate part of the nephron.
|
1. PCT - Carbonic anhydrase inhibitors
2. TAL - Loop diuretics 3. DCT - Thiazides 4. CCT - K+-sparing diuretics 5. Osmotic diuretics |
|
Drugs that modify water excretion can be classified into three groups of drugs. What are they?
|
1. Osmotic diuretics
2. ADH agonists 3. ADH antagonists |
|
Prototypes and mechanism of action of carbonic anhydrase inhibitors?
|
1. Acetazolamide, a sulfonamide derivative.
2. Inhibits carbonic anhydrase in the brush border and intracellular carbonic anhydrase in the PCT cells |
|
Major effect of carbonic anhydrase inhibitors?
|
1. Bicarbonate diuresis; body bicarbonate is thus depleted, and metabolic acidosis results.
2. In the CNS, acidosis of the CSF results in hyperventilation, which can protect against high-altitude sickness |
|
Clinical uses of carbonic anhydrase inhibitors?
|
1. Treatment of glaucoma
2. Prevent acte mountain sickness 3. Only used for their diuretic effect if edema is accompanied by significant metabolic alkalosis |
|
Prototypes and mechanism of action of loop diuretics?
|
1. Furosemide
2. Bumetanide 3. Ethacrynic acid 4. The first two are sulfonamide derivatives, ethacrynic acid is a phenoxyacetic acid derivative. 5. Inhibit the co-transport of sodium, potassium, and chloride. |
|
Effects of loop diuretics?
|
1. Massive sodium chloride diuresis
2. Edema fluid is rapidly excreted and blood volume may be significantly reduced 3. Calcium excretion is significantly increased 4. Ethacrynic acid is a moderate uricosuric agent 5. Hypokalemic alkalosis may occur |
|
Clinical use of loop diuretics?
|
1. Major use in edematous states (heart failure, ascites, pulmonary edema)
2. Sometimes used in HTN if thiazides are inadequate 3. Treatment of hypercalcemia |
|
Important toxicities of loop diuretics?
|
1. Hypokalemic metabolic acidosis
2. Hypovolemia and CVS complications 3. Ototoxicity |
|
Prototypes and mechanism of action of thiazides?
|
1. Hydrochlorothiazide, and all the other members of this group are suflonamide derivatives.
2. Active by the oral route 3. Inhibits sodium chloride transport in the early segment of the DCT |
|
Four thiazide diuretics?
|
1. Hydrochlorothiazide
2. Chlorothiazide 3. Chlorthalidone 4. Indapamide |
|
The major effects of thiaizide diuretics?
|
1. Sodium and chloride diuresis
2. Hypokalemic metabolic alkalosis may occur 3. Reabsorption of calcium from the urine is increased, and the urine calcium content is decreased - the opposite of loop diuretics 4. Reduction of blood pressure |
|
Clinical uses of thiazides?
|
1. Reduction of blood pressure
2. Chronic therapy of edematous conditions 3. Chronic renal calcium stone formation |
|
Toxicities of thiazides?
|
1. Massive sodium diuresis with hyponatremia
2. Potassium wasting 3. Significant hypoglycemia in diabetic patients 4. Serum lipid and uric acid levels are also increased in some patients |
|
Prototypes and mechanism of action of potassium sparing diuretics?
|
1. Spironolactone
2. Amilioride 3. Triamterene 4. Steroid derivatives and act as pharmacologic antagonists of aldosterone in the collecting tubule. 5. Reduce the expression of genes controlling synthesis of epithelial sodium ion channels and Na/K-ATPase |
|
Effects of potassium sparing diuretics?
|
1. Increase sodium clearance and decrease in potassium and hydrogen exchange.
2. May cause hyperkalemic metabolic acidosis |
|
clinical use of potassium sparing diuretics?
|
1. Aldosteronism is an important indication for spironolactone
2. Potassium wasting caused by chronic use of loop or thiazide diuretics |
|
Toxicities of potassium sparing diuretics?
|
1. Hyperkalemia
2. Spironolactone may cause endocrine abnormalities, including gynecomastia and antiandrogenic effects |
|
Prototype and mechanism of action of osmotic diuretics?
|
1. Mannitol
2. Freely filtered at the glomerulus but poorly reabsorbed from the tubule. They hold water by an "osmotic" effect. The major location of action is the PCT |
|
Effects of osmotic diuretics?
|
1. Increase urine output
2. Reduce brain volume and ICP. A similar effect occurs in the eye |
|
Clinical use of osmotic diuretics?
|
1. Maintain high urine flow
2. Reduce IOP in acute glaucoma and neurologic conditions |
|
Toxicities of osmotic diuretics?
|
1. Hyponatremia
2. Pulmonary edema 3. Headache, nausea, and vomiting are common |
|
Prototypes and mechanism of action of ADH agonists and antagonists
|
1. ADH and desmopressin - agonists
2. Demeclocycline and lithium ion are ADH antagonists 3. ADH activates V2 receptors, facilitating water reabsorption from the CCT. Antagonists block these. |
|
Effects and clinical uses of ADH agonists/antagonists
|
1. ADH and desmopressin reduce urine volume and increase its concentration. Useful in pituitary diabetes insipidus.
2. SIADH can be treated with demeclocycline; lithium also works but with a greater toxicity |
|
Toxicities of ADH antagonists/agonists
|
1. ADH or desmopressin may cause dangerous hyponatremia
2. In children younger than 8 years, demeclocycline (and other tetracyclines) causes bone and teeth abnormalities 3. Lithium causes nephrogenic diabetes insipidus; because of its other toxicities lithium is never used to treat SIADH. |
|
What is a bicarbonate diuretic?
|
A diuretic that selectively increases bicarbonate excretion. Example: a carbonic anhydrase inhibitor
|
|
What is the diluting segment?
|
A segment of the nephron that removes solute without water; TAL and DCT are active salt-absorbing segments that are not permeant to water
|
|
What is hyperchloremic metabolic acidosis?
|
A shift in body electrolyte and pH balance involving elevated chloride, diminished bicarbonate concentration, and a decrease in pH in the blood. Typical result of bicarbonate diuresis
|
|
What is a bicarbonate diuretic?
|
A diuretic that selectively increases bicarbonate excretion. Example: a carbonic anhydrase inhibitor
|
|
What is hypokalemic metabolic alkalosis?
|
A shift in body electrolyte balance and pH involving a decrease in serum potassium and an increase in blood pH. Typical result of loop and thiazide diuretic actions
|
|
What is the diluting segment?
|
A segment of the nephron that removes solute without water; TAL and DCT are active salt-absorbing segments that are not permeant to water
|
|
What is hyperchloremic metabolic acidosis?
|
A shift in body electrolyte and pH balance involving elevated chloride, diminished bicarbonate concentration, and a decrease in pH in the blood. Typical result of bicarbonate diuresis
|
|
What is nephrogenic diabetes insipidus?
|
Loss of urine-concentrating ability in the kidney caused by lack of responsiveness to ADH (ADH is normal or high)
|
|
What is pituitary diabetes insipidus?
|
Loss of urine-concentrating ability in the kidney caused by lack of ADH (ADH is low or absent)
|
|
What is hypokalemic metabolic alkalosis?
|
A shift in body electrolyte balance and pH involving a decrease in serum potassium and an increase in blood pH. Typical result of loop and thiazide diuretic actions
|
|
What is nephrogenic diabetes insipidus?
|
Loss of urine-concentrating ability in the kidney caused by lack of responsiveness to ADH (ADH is normal or high)
|
|
What are potassium-sparing diuretics?
|
A diuretic that reduces the exchange of potassium for sodium in the CCT; a drug that increases sodium and reduces potassium excretion. Example: aldosterone antagonists
|
|
What is pituitary diabetes insipidus?
|
Loss of urine-concentrating ability in the kidney caused by lack of ADH (ADH is low or absent)
|
|
Uricosuric diuretic?
|
A diuretic that increases uric acid excretion, usually by inhibiting uric acid reabsorption in the PCT. Example: ethacrynic acid
|
|
What are potassium-sparing diuretics?
|
A diuretic that reduces the exchange of potassium for sodium in the CCT; a drug that increases sodium and reduces potassium excretion. Example: aldosterone antagonists
|
|
Uricosuric diuretic?
|
A diuretic that increases uric acid excretion, usually by inhibiting uric acid reabsorption in the PCT. Example: ethacrynic acid
|